Temperature and Heart Failure—The Exposure-Response Curve

• by Jagadeesh Puvvula, Sameed Ahmed M. Khatana

• October 29, 2026

Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1–7), in Acute Heart Failure: Insights from the PUSH-AHF trial

• by Stijn Legtenberg, Karine Santos, Iris E. Beldhuis, Oliver Hartmann, Lara E.E.C. Zonneveld, Peter van der Meer, Jan A. Krikken, Wybe Nieuwland, Dirk J. van Veldhuisen, Adriaan A. Voors, Kevin Damman, Jozine M. ter Maaten

• September 4, 2026

FDA adds generic valganciclovir oral solution

 The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

• by Mouj Hijazi

• October 28, 2026

• 2 min

Influence of left ventricular ejection fraction on the clinical outcome of percutaneous coronary interventions in heart transplant patients

• by Luisa Elbinger, Tobias Schupp, Michael Behnes, Ibrahim Akin, Angelika Costard-Jäckle, Rene Schramm, Tanja Rudolph, Volker Rudolph, Mohamed Ayoub

• October 7, 2026